225 related articles for article (PubMed ID: 21428704)
1. Preparation and characterization of nanocapsules for colon-targeted drug delivery system.
Kshirsagar SJ; Bhalekar MR; Patel JN; Mohapatra SK; Shewale NS
Pharm Dev Technol; 2012; 17(5):607-13. PubMed ID: 21428704
[TBL] [Abstract][Full Text] [Related]
2. Design, development and in vitro-in vivo study of a colon-specific fast disintegrating tablet.
Kshirsagar SJ; Bhalekar MR; Umap RR
Pharm Dev Technol; 2011 Oct; 16(5):449-56. PubMed ID: 20486875
[TBL] [Abstract][Full Text] [Related]
3. Comparison of simple Eudragit microparticles loaded with prednisolone and Eudragit-coated chitosan-succinyl-prednisolone conjugate microparticles: Part I. Particle characteristics and in vitro evaluation as a colonic delivery system.
Onishi H; Kikuchi H; Machida Y
Drug Dev Ind Pharm; 2012 Jul; 38(7):800-7. PubMed ID: 22077373
[TBL] [Abstract][Full Text] [Related]
4. Design and development of liposomes for colon targeted drug delivery.
Gupta AS; Kshirsagar SJ; Bhalekar MR; Saldanha T
J Drug Target; 2013 Feb; 21(2):146-60. PubMed ID: 23373543
[TBL] [Abstract][Full Text] [Related]
5. Colon-targeted celecoxib-loaded Eudragit® S100-coated poly-ε-caprolactone microparticles: preparation, characterization and in vivo evaluation in rats.
Ghorab DM; Amin MM; Khowessah OM; Tadros MI
Drug Deliv; 2011; 18(7):523-35. PubMed ID: 21793779
[TBL] [Abstract][Full Text] [Related]
6. Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD).
Kumar J; Newton A
Antiinflamm Antiallergy Agents Med Chem; 2016; 15(2):101-117. PubMed ID: 27449742
[TBL] [Abstract][Full Text] [Related]
7. Polymeric three-layered particles for the delivery of prednisolone to the lower gastrointestinal tract in rats.
Fukushima K; Prabha T; Ito Y; Sugioka N; Takada K
Drug Dev Ind Pharm; 2011 Mar; 37(3):335-41. PubMed ID: 21244236
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use.
Limayem Blouza I; Charcosset C; Sfar S; Fessi H
Int J Pharm; 2006 Nov; 325(1-2):124-31. PubMed ID: 16872764
[TBL] [Abstract][Full Text] [Related]
9. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
Krishnamachari Y; Madan P; Lin S
Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
[TBL] [Abstract][Full Text] [Related]
10. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
[TBL] [Abstract][Full Text] [Related]
11. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery.
Kendall RA; Alhnan MA; Nilkumhang S; Murdan S; Basit AW
Eur J Pharm Sci; 2009 Jun; 37(3-4):284-90. PubMed ID: 19491017
[TBL] [Abstract][Full Text] [Related]
12. Development of pH- and enzyme-controlled, colon-targeted, pulsed delivery system of a poorly water-soluble drug: preparation and in vitro evaluation.
Lai H; Lin K; Zhang W; Zhang Z; Jie L; Wu Y; He Q
Drug Dev Ind Pharm; 2010 Jan; 36(1):81-92. PubMed ID: 19640246
[TBL] [Abstract][Full Text] [Related]
13. Eudragit S100 coated microsponges for Colon targeting of prednisolone.
Kumari A; Jain A; Hurkat P; Tiwari A; Jain SK
Drug Dev Ind Pharm; 2018 Jun; 44(6):902-913. PubMed ID: 29260916
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
15. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.
Kotagale N; Maniyar M; Somvanshi S; Umekar M; Patel CJ
Pharm Dev Technol; 2010; 15(4):431-7. PubMed ID: 20236031
[TBL] [Abstract][Full Text] [Related]
16. Formulation and evaluation of chitosan microspheres of aceclofenac for colon-targeted drug delivery.
Umadevi SK; Thiruganesh R; Suresh S; Reddy KB
Biopharm Drug Dispos; 2010 Oct; 31(7):407-27. PubMed ID: 20848388
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis.
Oosegi T; Onishi H; Machida Y
Int J Pharm; 2008 Feb; 348(1-2):80-8. PubMed ID: 17714892
[TBL] [Abstract][Full Text] [Related]
18. Rifaximin - Chitosan Nanoparticles for Inflammatory Bowel Disease (IBD).
Kumar J; Newton AMJ
Recent Pat Inflamm Allergy Drug Discov; 2017; 11(1):41-52. PubMed ID: 28034350
[TBL] [Abstract][Full Text] [Related]
19. Formulation development and in-vitro/in-vivo correlation for a novel Sterculia gum-based oral colon-targeted drug delivery system of azathioprine.
Nath B; Nath LK
Drug Dev Ind Pharm; 2013 Nov; 39(11):1765-73. PubMed ID: 23110370
[TBL] [Abstract][Full Text] [Related]
20. Design of pH-sensitive microspheres for the colonic delivery of the immunosuppressive drug tacrolimus.
Lamprecht A; Yamamoto H; Takeuchi H; Kawashima Y
Eur J Pharm Biopharm; 2004 Jul; 58(1):37-43. PubMed ID: 15207535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
